Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLI for Relapsed Malignancies After Allogeneic Transplant
NCT00003887Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Aug 1998
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donor lymphocytes in breast cancer, chronic myeloproliferative neoplasms (MPN), gestational trophoblastic tumor (GTN), kidney cancer, leukemia, sponsored by Fred Hutchinson Cancer Center. Started Aug 1998; status: completed.
02
Drugs
donor lymphocytes
03
Conditions
breast cancerchronic myeloproliferative neoplasms (MPN)gestational trophoblastic tumor (GTN)kidney cancerleukemia
Beyond the preview
Go deeper on NCT00003887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003887.